Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)
Hong Kong · Delayed Price · Currency is HKD 18.58
+0.08 (0.43%)
Jul 9, 2026, 4:08 PM HKT
HKG:1877 Market Cap
HKG:1877 has a market cap or net worth of 36.6 billion as of July 9, 2026. Its market cap has increased by 2.81% in one year.
Market Cap
36.60B
Enterprise Value
38.42B
Revenue
3.10B
Ranking
n/a
PE Ratio
n/a
Stock Price
18.58
Market Cap Chart
Since December 24, 2018, HKG:1877's market cap has increased from 18.06B to 36.60B, an increase of 102.66%. That is a compound annual growth rate of 9.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 36.60B | 5.59% |
| Dec 31, 2025 | 34.66B | 39.72% |
| Dec 31, 2024 | 24.81B | -37.28% |
| Dec 29, 2023 | 39.55B | -38.85% |
| Dec 30, 2022 | 64.67B | -7.04% |
| Dec 31, 2021 | 69.57B | -9.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Akeso | 89.95B |
| Sino Biopharmaceutical | 85.94B |
| RemeGen | 70.02B |
| Biocytogen Pharmaceuticals (Beijing) | 47.76B |
| 3SBio | 45.69B |
| Shanghai Henlius Biotech | 36.74B |
| Genscript Biotech | 29.54B |
| InnoCare Pharma | 28.03B |